Aging

BIO5 members Brian Erstad and Bonnie LaFleur are leading a Phase 3 University of Arizona clinical trial to study whether rapamycin can support healthy aging and immune function in adults 65 and older, made possible by $12 million in philanthropic support from alumnus Ken Coit.

BIO5 member Roberta Brinton leads a National Institute on Aging training grant that supports University of Arizona graduate students in translational Alzheimer’s disease research, helping them gain the skills needed to turn laboratory discoveries into future treatments.

Two scientists combine complementary strengths in RNA biology and aging neuron research to advance new approaches in studying ALS, supported by the University of Arizona BIO5 Institute.